Propranolol use in PHACE syndrome with cervical and intracranial arterial anomalies: Collective experience in 32 infants

Pediatric Dermatology

Volumn 30, Issue 1, 2013, Pages 71-89

  Metry, Denise ^a,b   Frieden, Ilona J ^c,d   Hess, Christopher ^d   Siegel, Dawn ^e   Maheshwari, Mohit ^e   Baselga, Eulalia ^f   Chamlin, Sarah ^g   Garzon, Maria ^h   Mancini, Anthony J ^f,g   Powell, Julie ⁱ   Drolet, Beth A ^e  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e MEDICAL COLLEGE OF WISCONSIN   (United States)

^f HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^g NORTHWESTERN UNIVERSITY   (United States)

^h Och Spine at New York Presbyterian Hospitals   (United States)

ⁱ UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; PROPRANOLOL; VINCRISTINE;

ARTICLE; BLOOD PRESSURE; BRAIN MALFORMATION; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONSULTATION; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; EYE MALFORMATION; FOLLOW UP; HEART DISEASE; HEMANGIOMA; HUMAN; INFANT; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; POSTERIOR FOSSA HEMANGIOMA ARTERIAL LESION CARDIAC ABNORMALITY EYE ABNORMALITY SYNDROME; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYSTEMIC THERAPY; TISSUE NECROSIS;

ABNORMALITIES, MULTIPLE; ADMINISTRATION, ORAL; ADRENERGIC BETA-ANTAGONISTS; AORTIC COARCTATION; CENTRAL NERVOUS SYSTEM VASCULAR MALFORMATIONS; CERVICAL VERTEBRAE; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EYE ABNORMALITIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NEUROCUTANEOUS SYNDROMES; PROPRANOLOL; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STROKE; TREATMENT OUTCOME;

EID: 84872293610     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2012.01879.x     Document Type: Article

References (43)

1. Kilcline C, Frieden IJ,. Infantile hemangiomas: how common are they? A systematic review of the literature. Pediatr Dermatol 2008; 25: 168-173.
2. Leaute-Labrèze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008; 358: 2649-2651.
3. Frieden IJ, Reese V, Cohen D,. PHACE syndrome: the association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects and eye abnormalities. Arch Dermatol 1996; 132: 307-311.
4. Haggstrom AN, Garzon MC, Baselga E, et al. Risk for PHACE syndrome in infants with large facial hemangiomas. Pediatrics 2010; 126: 418-426.
5. Burrows PE, Robertson RL, Mulliken JB, et al. Cerebral vasculopathy and neurologic sequelae in infants with cervicofacial hemangioma: report of eight patients. Radiology 1998; 207: 601-607.
6. Drolet BA, Dohil M, Golomb MR, et al. Early stroke and cerebral vasculopathy in children with facial hemangiomas and PHACE association. Pediatrics 2006; 117: 959-964.
7. Siegel DH, Tefft KA, Johnson C, et al. Stroke in children with PHACE syndrome: a systematic review of the literature. Stroke 2012; 43: 1672-1674.
8. Rao RP, Drolet BA, Holland KE, et al. PHACES association: a vasculocutaneous syndrome. Pediatr Cardiol 2008; 29: 793-799.
9. Dobkin BH,. Orthostatic hypotension as a risk factor for symptomatic occlusive cerebrovascular disease. Neurology 1989; 39: 30-34.
10. Iwama T, Hashimoto N, Yonekawa Y,. The relevance of hemodynamic factors to perioperative ischemic complications in childhood moyamoya disease. Neurosurgery 1996; 38: 1120-1125.
11. Novak V, Hu K, Desrochers L, et al. Cerebral flow velocities during daily activities depend on blood pressure in patients with chronic ischemic infarctions. Stroke 2010; 41: 61-66.
12. Chou PS, Guo YC,. Limb-shaking transient ischemic attacks in an adult PHACE syndrome: a case report and review of the literature. Neurol Sci 2011; 33: 305-307.
13. Metry D, O'Conner S, Drolet BA,. Migraine-like headaches in PHACE syndrome. (in press).
14. Metry DW, Garzon MC, Drolet BA, et al. PHACE syndrome: current knowledge, future directions. Pediatr Dermatol 2009; 26: 381-398.
15. Brandling-Bennett HA, Metry DW, Baselga E, et al. Infantile hemangiomas with unusually prolonged growth phase: a case series. Arch Dermatol 2008; 144: 1632-1637.
16. Drolet BA, Pope E, Juern AM, et al. Gastrointestinal bleeding in infantile hemangioma: a complication of segmental, rather than multifocal, infantile hemangiomas. J Pediatr 2012; 160: 1021-1026.e3.
17. Durr ML, Meyer AK, Huoh KC, et al. Airway hemangiomas in PHACE syndrome. Laryngoscope 2012 (in press).
18. Haggstrom AN, Skillman S, Garzon MC, et al. Clinical spectrum and risk of PHACE syndrome in cutaneous and airway hemangiomas. Arch Otolaryngol Head Neck Surg 2011; 137: 680-687.
19. Hess CP, Fullerton HJ, Metry DW, et al. Cervical and intracranial arterial anomalies in 70 patients with PHACE syndrome. AJNR Am J Neuroradiol 2010; 31: 1980-1986.
20. Poindexter G, Metry DW, Barkovich AJ, et al. PHACE syndrome with intracerebral hemangiomas, heterotopia, and endocrine dysfunction. Pediatr Neurol 2007; 36: 402-406.
21. Rosbe KW, Suh KY, Meyer AK, et al. Propranolol in the management of airway infantile hemangiomas. Arch Otolaryngol Head Neck Surg 2010; 136: 658-665.
22. Suh KY, Rosbe KW, Meyer AK, et al. Extensive airway hemangiomas in two patients without beard hemangiomas. Pediatr Dermatol 2011; 28: 347-348.
23. Metry D, Heyer G, Hess C, et al. Consensus statement on diagnostic criteria for PHACE syndrome. Pediatrics 2009; 124: 1447-1456.
24. Haggstrom AN, Lammer EJ, Schneider RA, et al. Patterns of infantile hemangiomas: new clues to hemangioma pathogenesis and embryonic facial development. Pediatrics 2006; 117: 698-703.
25. Beslow LA, Jordan LC,. Pediatric stroke: the importance of cerebral arteriopathy and vascular malformations. Childs Nerv Syst 2010; 26: 1263-1273.
26. Johnson BA, Heiserman JE, Drayer BP, et al. Intracranial MR angiography: its role in the integrated approach to brain infarction. AJNR Am J Neuroradiol 1994; 15: 901-908.
27. Vasaiwala R, Saija K, Setabutr P,. Novel management of the microphthalmic orbit in a patient with PHACE syndrome. Ophthal Plast Reconstr Surg 2011; 27: 156-158.
28. Solomon T, Ninnis J, Deming D, et al. Use of propranolol for treatment of hemangiomas in PHACE syndrome. J Perinatol 2011; 31: 739-741.
29. Manunza F, Syed S, Laguda B, et al. Propranolol for complicated infantile hemangiomas: a case series of 30 infants. Br J Dermatol 2010; 162: 466-468.
30. Hernandez-Martin S, Lopez-Gutierrez JC, Lopez-Fernandez S, et al. Brain perfusion SPECT in patients with PHACES syndrome under propranolol treatment. Eur J Pediatr Surg 2011; 22: 54-59.
31. Johnston GD, Finch MB, Shanks RG,. Peripheral vascular effects of bufuralol in hypertensive and normal subjects: a comparison with propranolol and pindolol. Eur J Clin Pharmacol 1986; 30: 649-652.
32. Joint Formulary Committee. British national formulary, Vol. 54. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, 2007.
33. Stringer MD, Bentley PG,. Peripheral gangrene associated with β-blockade. Br J Surg 1986; 73: 1008.
34. Vale JA, Jefferys DB,. Peripheral gangrene complicating beta-blockade. Lancet 1978; 1: 1216.
35. Maguiness SM, Hoffman WY, McCalmont TH, et al. Early white discoloration of infantile hemangioma: a sign of impending ulceration. Arch Dermatol 2010; 146: 1235-1239.
36. Hermans DJ, van Baynum IM, Schultze Kool LJ, et al. Propranolol, a very promising treatment of ulceration in infantile hemangiomas: a study of 20 cases with matched historical controls. J Am Acad Dermatol 2011; 64: 833-838.
37. Webb AJ, Fischer U, Rothwell PM,. Effects of β-blocker selectivity on blood pressure variability and stroke: a systematic review. Neurology 2011; 77: 731-737.
38. Reiter MJ,. Cardiovascular drug class specificity: β-blockers. Prog Cardiovasc Dis 2004; 47: 11-33.
39. Webb AJS, Fischer U, Mehta Z, et al. Effects of antihypertensive-drug class on interindividual variation in BP and risk of stroke: a systematic review and meta-analysis. Lancet 2010; 375: 906-915.
40. Schurks M, Rist PM, Bigal ME, et al. Migraine and cardiovascular disease: systematic review and meta-analysis. Br Med J 2009; 339: b3914.
41. Alvarez Sabin J, Molins A, Turõn A, et al. [Migraine-infarct in patients treated with β-blockers.] Rev Clin Esp 1993; 192: 228-230.
42. Mendizabal JE, Greiner F, Hamilton DO, et al. Migrainous stroke causing thalamic infarction and amnesia during treatment with propranolol. Headache 1997; 37: 594-596.
43. Bardwell A, Trott JA,. Stroke in migraine as a consequence of propranolol. Headache 1987; 27: 381-383.